Group | Number of samples | Time points (h) | Study days | Blood volume collected | Anticoagulant | |
---|---|---|---|---|---|---|
Male | Female | |||||
Trospium chloride ER tablets 60 mg OROS tablets (test product) | 03 | 00 | 0 h before administration and 1, 3, 5, 8, 10, 12, 14, 16, 18, 21, 24 h after administration | 1 day | 0.7 mL | K3 EDTA |
Sanctura® XR capsules 60 mg (innovator CAPSULES) (reference product) | 02 | 01 | 0 h before administration and 1, 3, 5, 8, 10, 12, 14, 16, 18, 21, 24 h after administration | 1 day | 0.7 mL | K3 EDTA |